Trademark: 87317376
Status Date
Tuesday, February 27, 2018
Registration Number
5410374
Registration Date
Tuesday, February 27, 2018
Filing Date
Monday, January 30, 2017
Published for Opposition
Tuesday, December 12, 2017
9 Electronic databases and computer programs for retrieving, compiling, integrating and sending data relating to research on type II diabetes, prediabetes and their associated acute or chronic complications in particular experimental data concerning the targets, biomarkers, cellular models and animal testing models which are being used or developed; Electronic databases and computer programs for retrieving, compiling, integrating and sending data relating to methods for the preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Electronic databases and computer programs for retrieving, compiling, integrating and sending medical data relating to the condition of patients monitored for the preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications
5 Pharmaceutical preparations and substances, preparations for medical use, for the preventive and curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Preparations, products and devices for medical use, in particular, diagnostic biomarkers and cellular models for the in vivo, ex vivo or in vitro diagnosis of type II diabetes, of prediabetes and their associated acute or chronic complications; Preparations, products and devices, in particular, diagnostic biomarkers and cellular models for the medical follow-up of patients at risk or of patients suffering from type II diabetes, prediabetes and their associated acute or chronic complications; Preparations, products and devices in particular diagnostic biomarkers and cellular models for the selection and assessment of drugs and their compounds for their preventive and curative properties towards type II diabetes, prediabetes and their associated acute or chronic complications
1 Active principles, namely, active chemical ingredients used in manufacturing pharmaceuticals for treating type II diabetes, prediabetes and their acute or chronic complications
42 Scientific research in the field of prevention, diagnosis, screening, preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Scientific research, in particular clinical research on the assessment of the effects of drugs and their compounds having preventive or curative properties of type II diabetes, prediabetes and their acute or chronic complications; Development and validation of tests for the diagnosis and medical follow-up of patients at risk or of patients suffering from type II diabetes, prediabetes and their associated acute or chronic complications; Development and validation of biological tests in vitro, ex vivo and in vivo for sorting and selecting compounds, products and substances intended for the preventive or curative treatment of type II diabetes, prediabetes and their associated acute or chronic complications
Feb 27, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Feb 27, 2018
Registered-Principal Register
Dec 12, 2017
Official Gazette Publication Confirmation E-Mailed
Dec 12, 2017
Published For Opposition
Nov 22, 2017
Notification Of Notice Of Publication E-Mailed
Oct 31, 2017
Approved For Pub - Principal Register
Oct 21, 2017
Teas/Email Correspondence Entered
Oct 20, 2017
Correspondence Received In Law Office
Oct 20, 2017
Teas Response To Office Action Received
Apr 25, 2017
Notification Of Non-Final Action E-Mailed
Apr 25, 2017
Non-Final Action E-Mailed
Apr 25, 2017
Non-Final Action Written
Apr 25, 2017
Assigned To Examiner
Feb 2, 2017
New Application Office Supplied Data Entered
Feb 2, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
